ALIPAY+
16.12.2022 05:08:36 CET | Business Wire | Press release
Alipay+, the provider of global cross-border digital payments and marketing solutions, today rolled out its first year-end promotion campaign with merchants across Asia and Europe, in collaboration with five Asian e-wallet partners - AlipayHK (Hong Kong SAR, China), GCash (Philippines), Kakao Pay (South Korea), TrueMoney (Thailand) and Touch ‘n Go eWallet (Malaysia).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221215006131/en/
Great in-destination merchant offers are available where Alipay+ operates, including Japan, South Korea, Singapore and various countries in Europe. (Graphic: Business Wire)
The promotion campaign sees the participation of over one million merchants in retail, F&B, tourist attractions and hospitality across major travel destinations where Alipay+ is accepted, including Japan, South Korea, Singapore, and various countries in Europe. During the campaign period, users of participating e-wallets can enjoy a wide range of deals offered by Alipay+ together with merchant partners in each destination.
Leveraging the Alipay+ marketing solutions, merchants are able to create and customize promotions in the forms of either digital coupons or instant discounts. Merchants can also distribute digital coupons in multiple e-wallet apps at the same time to achieve better marketing efficiency and scalability.
Japan
Between 15 December 2022 and 15 February 2023, users of AlipayHK, GCash, Kakao Pay, TrueMoney and Touch ’n Go eWallet will receive three coupons in their respective apps upon arrival in Japan. Each of the three coupons offers a ¥50 discount with a minimum of ¥51 spent, and can be redeemed at all local merchants accepting Alipay+ payments across Japan.
In addition, Alipay+ has also introduced other merchant-specific coupons. Such offers include, but are not limited to:
- ¥1,000 OFF with a minimum of ¥5,000 spent at merchants such as Daimaru Department Store, Keio Department Store, Kintetsu Department Store, merchants at Fukuoka Airport, BicCamera stores, and many others.
- ¥500 OFF with a minimum of ¥3,000 spent at merchants such as Tsuruha Drug Store, Sapporo Drug Store, and many others.
E-wallet users are able to access and browse all merchant-specific coupons in their respective apps.
Through the integration of Alipay+ solutions, over one million brick-and-mortar merchants in Japan including airports, shopping malls, convenience stores, cafes, and restaurants are now able to accept various mobile payment methods.
South Korea
From now till the end of December, users of AlipayHK, GCash, TrueMoney and Touch ‘n Go eWallet can redeem digital coupons by simply using the respective e-wallets to scan the Alipay+ in-store promotion QR code displayed at the store cashiers, and enjoy instant discounts of up to 10%, when they pay with their e-wallets via Alipay+ at local merchants.
Participating merchants include F&B brands like Paris Baguette, Haidilao, retailers such as Daiso, Galleria Department Store, as well as Lotte Duty Free, Shinsegae Duty Free, etc. Over 120,000 merchants in South Korea are now accept the payments made by these four e-wallets via Alipay+.
Singapore
From now till 31 January 2023, users of AlipayHK, GCash, Kakao Pay, TrueMoney and Touch ’n Go eWallet will be given three coupons upon arrival in Singapore and enjoy savings when shopping in Singapore.
- Coupon 1: SGD 1 off with a minimum of SGD 1.01 spent
- Coupon 2: SGD 3 off with a minimum of SGD 3.01 spent
- Coupon 3: SGD 8 off with a minimum of SGD 100 spent
Furthermore, Alipay+ has extended more promotions with various merchants at Changi Airport and Paragon Shopping Centre. Between 15 December 2022 and 31 January 2023, e-wallet users can enjoy three more deals:
- Coupon 1: SGD 5 off with a minimum of SGD 20 spent;
- Coupon 2: SGD 10 off with a minimum of SGD 100 spent;
- Coupon 3: SGD 18 off with a minimum of SGD 200 spent.
When taking a ComfortDelgro Taxi in Singapore, users can also claim SGD 2 off with a minimum spending of SGD 2.01.
Each e-wallet user can redeem up to three coupons during the campaign period.
Europe
In France, UK, Italy and Germany, Alipay+ has rolled out various promotions and deals with local merchants, including retail stores Printemps in France and city-wide vending machines in Milan, Rome and Venice to reward shoppers this holiday season.
Between now and 31 January 2023, users of Kakao Pay, GCash, TrueMoney and Touch ‘n Go eWallet can enjoy up to 10 EUR in instant discounts when paying with the respective e-wallets at the aforementioned merchants. In addition, Printemps in France is also offering e-wallet users a special 5% store-wide discount and a free bubble tea voucher at the Printemps Haussmann store. E-wallet users can visit the store information desks to check for specific details.
As of November 2022, Alipay+’s merchant coverage has reached 2.5 million. Its merchant network includes regional and global digital entertainment providers, lifestyle services, e-commerce platforms and a wide range of brick-and-mortar businesses that cover major airports, shopping centers, duty free shops, convenience stores, cafes, restaurants and tourism facilities.
The global merchant coverage of Alipay+ by sector includes over 1,000 online platforms, more than 10 major airports, over 90,000 convenience stores, over 360,000 restaurants, nearly 200,000 taxis and major hotel brands, department stores, duty-free shops and tourist facilities in Asia and Europe.
*Terms and conditions apply in coupon usage and redemption.
About Alipay+
Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing offers by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221215006131/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Thales Builds Cryptographic Security for the Age of AI and Post-Quantum Computing14.9.2026 09:00:00 CEST | Press release
Thales launches Luna 8, a new hardware security module (HSM) to provide future-ready, quantum resistant security to protect critical data and applications Powered by a Thales designed cryptographic processor, it delivers unparalleled performance, enhanced protection and the flexibility to adapt to new security needs Drawing on decades of cryptographic expertise, Luna 8 combines trusted security with support for emerging technologies, including post quantum cryptography According to the 2026 Thales Data Threat Report, the threat of Harvest Now, Decrypt Later (HNDL) attacks was the top-cited risk, with 59% of organizations reporting that they are prototyping and evaluating post-quantum cryptography (PQC) algorithms to prepare for the quantum era. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804748922/en/ ©Thales To help organizations turn this readiness into deployment,Thales, a global leader in advanced technologies, tod
U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations14.9.2026 09:00:00 CEST | Press release
Acceptance is based on pivotal Phase 3 data demonstrating rapid, durable and consistent skin clearance, including in high-impact sites, in a convenient once-daily pill Results from nearly 3,000 patients support potential for next-generation TYK2 inhibitor to redefine oral treatment expectations in psoriasis The Prescription Drug User Fee Act (PDUFA) target action date is in the first quarter of calendar year 2027 Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for zasocitinib (TAK-279) for the treatment of adults with moderate-to-severe plaque psoriasis. Zasocitinib is an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, which demonstrated rapid, durable and consistent skin clearance in Phase 3 plaque psoriasis studies.1-3 Addressing unmet needs in psoriasis treatment “Despite progress in psoriasis care, there remains a need for highly
SWISSto12 and Mitsubishi Electric Corporation Announce Strategic Partnership14.9.2026 09:00:00 CEST | Press release
The Memorandum of Understanding (MoU) and additional contract signal a new phase of collaboration on market development in the Asia Pacific (APAC) region SWISSto12 today announced a memorandum of understanding (MoU) with Mitsubishi Electric Corporation (MELCO) (TOKYO: 6503) to pursue joint opportunities on advanced payloads, radio frequency (RF) products, and market development in Japan and the APAC region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914982179/en/ Masahiko Arai, Executive Officer and Group President, Defense & Space Systems, Mitsubishi Electric, and Dr. Emile de Rijk, Chief Executive Officer, SWISSto12 Joint opportunities will leverage MELCO’s extensive satellite system expertise and integration capabilities together with SWISSto12’s proprietary 3D-printing designs and processes that form the foundation of its next-generation payloads—smaller, lighter, highly performant, yet built in materially shorter
Focused Support Launches Cavok STRIKE to Expand Link-16 Participation Across the Joint Force14.9.2026 07:00:00 CEST | Press release
Extending Link-16 interoperability without platform-level hardware integration Focused Support LLC today announced the launch of Cavok STRIKE, an integrated software capability that expands the Link-16 tactical battlespace picture by enabling additional operational platforms to participate in the Link-16 network. Modern battlefields have increasing numbers of unmanned systems, sensors, and supporting platforms operating throughout the joint battlespace. The rapid proliferation of Group 1, 2, and 3 UAS, including both expendable and recoverable systems, has created a growing need to integrate these assets into the broader tactical network. Many of these platforms provide operationally relevant information but have historically remained outside the Link-16 network due to limitations in size, weight, power, platform integration complexity, or acquisition cost. Cavok STRIKE addresses this gap by enabling platforms to participate in the Link-16 network as non-command-and-control participant
Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma14.9.2026 07:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted market authorization for the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for use on the fully automated LUMIPULSE® G immunoassay platform in Brazil. “ANVISA authorization of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays marks another important step in our mission to expand access to reliable, clinically meaningful blood-based biomarkers for clinicians and patients worldwide,” said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “By making both neurological biomarker assays available to laboratories on a single, fully automated platform, we are helping support more informed clinical decision-making across a broad range of neurological conditions and throughout the diagnostic pathway.” The Brazilian ANVISA authorizations are based on the already CE marked in vitro diagnostics (IVD) approvals of these two
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom